Company ProfilePremium

The GrowHub Limited

Company Profile Analysis

Ticker: TGHL

ESOMAR 23 Corporate BadgeISO Certifications Badge
The GrowHub Limited - Company showcase

Year Founded & Workforce

2024

The GrowHub Limited logo

The GrowHub Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

The GrowHub Limited Overview

The GrowHub Limited is a Singapore-based, Cayman-domiciled holding company that has marketed itself as a blockchain-enabled supply-chain traceability provider. It focuses on food and agricultural products in Asia-Pacific. Its proprietary GrowHub Platform runs on the public Polygon blockchain and bundles three functions: product traceability via QR/NFC consumer interfaces, anti-counterfeit authentication, and carbon tracking. Alongside it sit a small product-trading facilitation business and project-based IT professional services. Commercial traction has been minimal: revenue peaked at S$237k in FY2024 and fell to S$83k in FY2025. The FY2025 net loss of S$17.2M was driven overwhelmingly by S$12.9M of professional fees following a US$15M Nasdaq IPO in August 2025. By mid-2026 the company had a shareholders' deficit, faced Nasdaq delisting proceedings, and had signed a US$400M-valuation reverse merger with EnChem America. That deal would hand about 85% of the company to the battery-electrolyte maker and effectively repurpose the listing as a U.S. battery-materials vehicle.


Company's own description (paraphrased from FY2025 20-F and 424B4)

In its FY2025 annual report, the company describes itself as an investment holding company. Through its subsidiaries it provides product traceability, data analytics and product-trading facilitation, with an emphasis on authenticity and sustainability in the food supply chain. It identifies two divisions:

  1. GrowHub Platform: a blockchain-based service hosted on the Polygon network. It offers traceability, anti-counterfeit and carbon-management tools.

  2. Product trading facilitation: placing partner products into retail and online channels.

The IPO materials (2025) frame a vision of letting the world "consume with confidence." They described a third division, the GrowHub Innovation Centre in Western Australia, expected to generate revenue by the end of Q2 2025. The IPO closing press release (29 August 2025) instead listed the three divisions as the GrowHub Platform, product trading facilitation, and IT professional services. The 20-F notes that the Australian entity behind the Innovation Centre (GrowHub Innovation Centre Pty Ltd) was deregistered in December 2025. The Innovation Centre therefore appears to have been discontinued before it generated material revenue.

The 20-F risk factors state that the company was substantially dependent on the GrowHub Platform for revenue in FY2024 and FY2025. Revenue is project-based and comes from a small number of customers. Most revenue came from Singapore in both years.

Business model and revenue model

StreamNature (analyst characterization)Recognition
Professional service revenueProject-based platform implementation and IT/software services for brand owners and agenciesOver time
Subscription revenueSaaS access to the GrowHub Platform (traceability, anti-counterfeit, carbon modules)Over time
Sales of goodsTrading of food, agricultural, skincare and other products through retail and online channelsPoint in time
Consignment salesConsignment of partner goods (only FY2024: S$1.8k)Point in time

Revenue is reported in four streams (FY2025 20-F, Note on Revenue):

FY2025 mix: professional services 30.8%, subscription 28.4%, sales of goods 40.8%. Subscription, the only recurring stream, was S$23.6k (about US$18.3k) in FY2025. This is too small to call the company a SaaS business in economic terms, despite how it positions itself.

Value-chain position

GrowHub positions itself in the "trust layer" between producers and brand owners on one side and retailers and consumers on the other. It records supply-chain events (origin, processing, logistics) as immutable entries on the Polygon public chain. Consumers access these through QR codes and NFC/RFID tags. The company is an application-layer provider: it does not own blockchain infrastructure and relies on Polygon, Google and Amazon Web Services for hosting (20-F risk factors). Its trading arm sits downstream as a distributor or facilitator of premium food products. This reflects the founder's original "farm-to-table" export-partner model described in 2023 press coverage.

Customer types and end-markets

  • Brand owners and producers of premium food and agricultural goods. Named clients in 2023 press coverage included ManukaLife Honey, tangobar, Dirty Clean Food Oatmilk and Koufuku Granola (Asia Food Journal, 10 Mar 2023).

Government and quasi-government bodies: The company claims government collaborations in Japan, Bhutan and Australia (424B4). In September 2025 it signed a non-binding MoU with the Government of the Republic of Srpska (Bosnia and Herzegovina) covering ESG and traceability.

Carbon-project developers: (soil carbon and nature-based projects).

Regulated-industry and public-sector customers: These are cited generically in the risk factors.

Customer concentration is extreme. The largest customer was 66.4% of revenue in FY2022, 58.6% in FY2023 and 40.0% in FY2024. The top five were about 90% or more in each year.

Independent characterization

On the evidence of the audited accounts, GrowHub has not achieved product-market fit at commercial scale. Cumulative audited revenue across FY2023–FY2025 was S$448.6k. Cumulative net loss over the same period was S$21.4M, and the accumulated deficit reached S$23.9M at end-2025. In practice the business is a sub-scale, founder-funded technology and trading venture. Its main post-IPO strategic asset has been the Nasdaq listing itself, which the May–July 2026 EnChem transaction now seeks to repurpose. Investors should evaluate TGHL less as a traceability company and more as a pending reverse-merger vehicle. Its value depends on the merger closing, the post-merger Nasdaq listing approval, and EnChem America's economics.

Strategy

Stated strategy (pre-merger, from the 424B4)

The prospectus set out four growth strategies:

  1. Expand geographically within Asia-Pacific over two years.

  2. Invest in AI and data analytics.

  3. Grow market share in Australia, Japan, Malaysia, Bhutan and other existing markets.

  4. Establish a corporate venture capital arm.

Claimed competitive strengths were a one-stop traceability offering, government partnerships (Japan, Bhutan, Australia), a subscription SaaS model, early Web3-enabled traceability in APAC, and an experienced management team.

Stated uses of IPO proceeds were technology development, repayment of the related-party working-capital loan, expansion into new geographic markets, and working capital and general corporate purposes.

Execution against strategy (last 24 months)

InitiativeAnnouncedStatus at Oct 2026Assessment
GrowHub Innovation Centre (WA)2022–2025Entity deregistered Dec 2025Abandoned
Vietnam platform developmentEntity acquired Feb 2025Deregistered Oct 2025Abandoned within about 8 months
Australia market expansionIPO strategyAustralian entities deregisteredReversed
Government partnerships: Republic of Srpska MoU (ESG, carbon monitoring, traceability)9 Sep 2025No revenue or project contracts disclosedNon-binding; no measurable output
AI/data analytics investmentIPO strategyNo product disclosed; capex S$1.6k in FY2025No evidence of investment
Corporate venture capitalIPO strategyNo vehicle or investments disclosedNot executed
Repay related-party loanIPO use of proceedsS$2.40M repaid in 2025; S$3.15M CEO loan outstandingPartially executed
Reverse merger with EnChem AmericaTerm sheet 28–29 May 2026; merger agreement 14 Jul 2026Pending; outside date 2 Dec 2026Strategic pivot that supersedes the original strategy
Capital restructuring (authorized capital to US$2.525M; reverse split up to 1:200)EGM 5 Aug 2026Approved; split not yet effected as of research dateEnabler for merger and Nasdaq compliance

Medium-term targets and guidance

The company has issued no financial guidance or medium-term targets. The merger documentation implies a post-merger funding plan:

  • At least a US$200M shelf registration once TGHL is F-3 eligible.

  • Per Korean press, EnChem intends to raise at least US$200M in U.S. capital through the listed vehicle after the merger, drawn in phases by capital call. Uses would include raw materials, working capital, operation of the Georgia plant and North American customer supply.

ESG and sustainability commitments

None quantified.

Products & Services

GrowHub Platform (core division)

AttributeTraceability moduleAnti-counterfeit moduleCarbon management module
DescriptionRecords each supply-chain stage (origin farm, production method, transport route) as an immutable ledger entry on Polygon. Consumers view provenance by scanning a QR code through a web application.Validates product authenticity using RFID and NFC tags at supply-chain checkpoints. Aimed at brands facing counterfeiting, revenue loss and reputational damage.SaaS tool to track, monitor and measure carbon emissions or offsets. Initial use cases were soil-carbon markets; later positioned for nature-based projects such as reforestation (Srpska MoU).
Key capabilitiesPublic-chain anchoring; cloud transmission; consumer-facing provenance pages; analytics on consumer interactionsTag-based verification at checkpoints; consumer verificationEmissions and offset tracking; carbon-credit tracing
Target customerPremium food and agri brands; exporters; government agri bodiesBrand owners in food, skincare and premium goodsCarbon-project developers; corporates; governments
Launch / versionOperating since 2020–2021; no version history disclosed—Referenced from 2023
Pricing modelSubscription (SaaS) plus implementation fees; price points not disclosed——
FY2025 revenueNot disclosed by module. Total subscription revenue S$23.6k; professional services S$25.6k.——

Sources: 424B4; FY2025 20-F; Quality Assurance & Food Safety magazine; Asia Food Journal.

The company claimed in its prospectus to be among few Asia-Pacific operators of a public-blockchain traceability system where data goes directly to the cloud and to public chain records. It also claimed an early position in Web3-enabled traceability.

Data analytics and AI tools

The IPO prospectus lists investment in AI and data analytics as a growth strategy, and the Srpska MoU (September 2025) lists "AI data analytics tools" and "digital asset solutions" among the company's offerings. No standalone product names, launch dates or revenue have been disclosed.

Product trading facilitation

The company trades in food, agricultural, skincare and other products and places partners' goods in retail outlets and online channels. It operated through GrowHub Capital (Singapore), GrowHub Malaysia, GrowHub Japan and, until December 2025, GrowHub Trading (Australia). Revenue: sales of goods S$33.9k in FY2025, plus S$1.8k consignment in FY2024. Inventory write-offs were S$172.3k in FY2023, S$0.1k in FY2024 and S$1.7k in FY2025. Year-end inventory went from S$50.5k (FY2024) to nil (FY2025), which suggests the trading activity was being run down.

IT professional services and software development

These are project-based services: software development, consultancy and platform implementation. They were the largest stream in FY2023–FY2024 (S$76.8k, then S$175.5k) before falling to S$25.6k in FY2025.

GrowHub Innovation Centre (discontinued)

This was a planned third division at the FIPWA hub in Western Australia, offering rental and auxiliary services and an innovation/data hub. The 424B4 projected revenue from end-Q2 2025. The operating entity was deregistered in December 2025, and right-of-use assets fell from S$201.6k to S$13.8k with a lease-termination loss recorded.

Blockchain services

Aggregator descriptions mention "blockchain services" and rental/auxiliary services. No separate revenue is disclosed beyond the four streams above.

Financial Narrative

Data availability: Audited full-year income statements and cash-flow statements are available for FY2023–FY2025 (FY2025 20-F). Balance sheets are available for 31 Dec 2024 and 31 Dec 2025. FY2022 is available only partially: net loss S$1.9M (F-1, Oct 2024) and opening equity. FY2021 was not disclosed in the materials reviewed. A 2023 press article cited an estimated FY2022 revenue of US$750k (company-sourced and unaudited). That figure cannot be reconciled with the audited series and is excluded from the tables.

Income statement, S$ thousands

Source: FY2025 20-F, Consolidated Statements of Operations (XBRL R4). EBITDA and gross profit are analyst-derived. FY2025 net loss = US$13.38M.

Sources: F-1 (Oct 2024) for FY2022; FY2025 20-F for FY2023–FY2025.

Revenue CAGR FY2023–FY2025: -19.6% per year (S$128.5k to S$83.0k). Analyst calculation.

Adjusted view. Other expenses in FY2025 include a non-cash intangible-asset write-off of S$1,990,000. This wrote off the full remaining carrying value of the intangible acquired under the 2020 asset purchase agreement, whose consideration was revised to S$1.99M in 2021. The FY2023 figure includes a S$142.5k write-off. Excluding write-offs, FY2025 EBITDA was about S$-14.89M and FY2023 about S$-1.52M. Analyst calculation.

Other expenses detail (S$ thousand):

Source: FY2025 20-F XBRL R67. The FY2023 components sum to S$458.8k against S$456.8k on the face of the income statement, a small discrepancy within the source.

Interim data point (unaudited, six months to 30 June):

Source: 6-K with interim financial statements (H1 2025).

Derived H2 2025: revenue about S$19.7k and net loss about S$15.36M. H1 2025 showed only S$0.86M of "other expenses" with no separate professional-fee line. Essentially all of the S$12.9M FY2025 professional fees were therefore booked in H2 2025, after the August 2025 IPO. The 20-F extracts reviewed do not itemize these fees. They are the single most important unexplained item in the accounts, and investors should obtain the full 20-F MD&A discussion of them.

Balance sheet, S$ thousands

Source: FY2025 20-F (XBRL R2). FY2025 in US$: total assets 1.02M; total liabilities 3.32M; deficit -2.30M; cash 0.91M.

Equity history: shareholders' deficit was S$-2,467k at end-2022, S$-2,660k at end-2023, S$-1,670k at end-2024 and S$-2,956k at end-2025 (20-F statement of changes in equity). The group has never had positive book equity in the audited periods presented, including after raising US$15M gross in the IPO. The negative US$2.30M equity at end-2025 triggered the Nasdaq equity deficiency notice.

Cash flow, S$ thousands

Source: FY2025 20-F (XBRL R6). Free cash flow is analyst-derived.

FY2025 operating cash burn (S$14.0M, about US$10.9M) absorbed roughly 83% of the S$16.8M net equity raised that year. The company ended the year with S$1.16M in cash against S$4.27M of liabilities due within twelve months.

Ratios

ROE, ROIC, net debt/EBITDA and the cash conversion cycle are not meaningful: equity is negative, invested capital is negative, and EBITDA is negative. FY2023 balance-sheet ratios cannot be computed because the 31 Dec 2023 balance sheet was not in the documents reviewed.

Commentary on trends, inflections and drivers

Revenue. Revenue rose 84% in FY2024 on one-off professional-services projects, then fell 65% in FY2025. Revenue appears to have nearly stopped in H2 2025: about S$19.7k derived for the half year. No evidence of a recurring revenue base has emerged. Year-end receivables collapsed from S$139k to under S$1k, consistent with near-zero activity at year-end.

Cost structure. The defining inflection is the jump in professional fees, from S$0.6M to S$12.9M, concentrated after the IPO. It was accompanied by a 75% rise in staff costs and the S$1.99M intangible write-off. The write-off removed almost all of the company's long-lived assets, which suggests management no longer regarded the originally acquired platform asset as recoverable.

Funding model. Before the IPO the group was funded by founder-family loans: the father's facility of up to S$6M and the founder's facility of up to S$8M, both at 3% and repayable on 60 days' demand. The IPO replaced part of this, and S$2.4M was repaid in 2025. A S$3.15M CEO loan remained outstanding at end-2025, classified as current. The continuing demand-loan dependence on the controlling shareholder is a key liquidity variable.

Liquidity. The FY2025 accounts show current liabilities exceeding current assets by S$3.04M (US$2.36M), together with recurring losses. The company's continued operation has depended on the controlling shareholder's forbearance on the demand loan and on the EnChem transaction. The 20-F extracts reviewed did not show the auditor's going-concern wording, so it is not characterized here.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue stream (SGD K)

Revenue stream (SGD K)FY2023FY2024FY2025

Professional service revenue

76.8175.525.6

Subscription revenue

4.321.723.6

Sales of goods

47.438.033.9

Consignment sales

0.01.80.0

Total revenue

128.5237.083.0

Share of total revenue (%)

Share of total revenue (%)FY2023FY2024FY2025

Professional services

59.874.130.8

Subscription

3.39.228.4

Sales of goods

36.916.040.8

Consignment

0.00.80.0

YoY growth (%)

YoY growth (%)FY2024FY2025

Professional services

128.5-85.4

Subscription

406.88.5

Sales of goods

-19.9-10.8

Total revenue

84.4-65.0

Revenue by Segment

Recognition timing (SGD K)FY2023FY2024FY2025

Point in time

47.439.833.9

Over time

81.1197.249.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Group Entities

EntityJurisdictionIncorporatedPrincipal activityStatus

THE GROWHUB LIMITED

Cayman Islands

12 Apr 2024

Listed holding company

Active

THE GROWHUB INNOVATIONS COMPANY LIMITED (GrowHub BVI)

BVI

12 Apr 2024

Investment holding

Active

The GrowHub Innovations Company Pte. Ltd.

Singapore

17 Aug 2020

Investment holding

Active

GrowHub Carbon Pte. Ltd. (fka GrowHub (Apac))

Singapore

6 Jan 2020

Investment holding

Active

GrowHub Capital Pte. Ltd. (fka GrowHub Distribution (Singapore))

Singapore

11 Feb 2020

Agricultural product distribution

Active

GrowHub Technologies Pte. Ltd.

Singapore

23 Mar 2022

Blockchain authentication, tracing and data services

Active

GrowHub Malaysia Sdn. Bhd.

Malaysia

28 Feb 2022

Agricultural product distribution

Active

GrowHub Japan Co., Ltd.

Japan

30 Jul 2021

Agricultural product distribution and trading

Active

GrowHub Trading Pty Ltd

Australia

3 Apr 2020

Agricultural product trading

Deregistered Dec 2025

GrowHub Innovation Centre Pty Ltd

Australia

17 Mar 2022

Rental and auxiliary services (FIPWA hub)

Deregistered Dec 2025

GrowHub Vietnam LLC

Vietnam

9 Oct 2024

Blockchain platform development

Acquired Feb 2025 from a common director; deregistered Oct 2025

Income Statement

Metric (SGD K)FY2023FY2024FY2025

Revenue

128.5237.083.0

Purchases and other direct costs

-110.5-166.7-99.5

Gross profit (revenue less direct costs)

18.070.3-16.5

Inventory write-off

-172.3-0.1-1.7

Employee benefits expenses

-753.3-850.8-1,484.8

Professional fees

-235.6-621.6-12,912.0

Depreciation and amortization

-49.4-27.9-44.2

Operating lease expenses

-61.8-71.1-125.6

Other expenses

-456.8-809.0-2,339.0

Operating loss

-1,711.2-2,310.1-16,923.7

EBITDA (operating loss plus D&A)

-1,661.8-2,282.2-16,879.6

Interest expense

-119.7-159.5-90.8

Pre-tax loss

-1,793.4-2,367.6-17,200.8

Income tax (expense)/credit

-2.93.80.2

Net loss

-1,796.3-2,363.8-17,200.6

Net loss attributable to TGHL

-1,773.1-2,358.2-17,200.6

Key Financials

Net loss, extended series (SGD Mn)FY2022FY2023FY2024FY2025

Net loss

-1.9-1.80-2.36-17.20

Per-share data

Per-share dataFY2023FY2024FY2025

Basic and diluted EPS (SGD)

-0.08-0.11-0.75

Basic and diluted EPS (USD)

——-0.59

Dividends per share (USD)

000

Weighted average shares (million)

21.5521.5522.83

Margins (%)

Margins (%)FY2023FY2024FY2025

Gross margin

14.029.7-19.9

Operating margin

-1,331.4-974.7-20,382.2

EBITDA margin

-1,292.9-962.9-20,328.9

Net margin

-1,397.6-997.3-20,715.6

Other expenses component (SGD K)

Other expenses component (SGD K)FY2023FY2024FY2025

Marketing expenses

66.628.215.2

Penalty

58.44.34.6

Referral fee

0.0584.60.0

Intangible assets write-off

142.50.01,990.0

Other

191.3191.8329.2

Income Statement (Half-Yearly)

H1 metric (SGD K)H1 2024H1 2025

Revenue

180.563.3

Employee benefits expenses

-281.7-779.6

Other expenses

-643.3-857.9

Operating loss

-836.2-1,721.1

Net loss

-784.0-1,844.6

Balance Sheet

Balance sheet item (SGD K)FY2024FY2025

Cash and cash equivalents

546.31,163.9

Accounts receivable, net

139.30.9

Inventories, net

50.50.0

Deferred offering costs

927.30.0

Other current assets

322.769.5

Total current assets

1,986.11,234.3

Intangible assets, net

2,082.866.9

Plant and equipment, net

20.80.4

Right-of-use assets

201.613.8

Total assets

4,291.41,315.4

Accounts payable

19.80.2

Accruals and other current liabilities

254.91,105.2

Working capital loan from related party

5,475.53,151.7

Operating lease liabilities (total)

210.714.1

Total liabilities

5,961.54,271.7

Total shareholders' deficit

-1,670.2-2,956.3

Accumulated losses

-6,745.6-23,946.2

Additional paid-in capital

5,021.920,698.5

Liquidity & Coverage Ratios

Derived balance sheet metrics (SGD K)FY2024FY2025

Total debt (related-party loan; all current)

5,475.53,151.7

Long-term debt

0.00.0

Net debt

4,929.21,987.8

Working capital

-3,822.7-3,035.3

Goodwill and intangibles

2,082.866.9

Cash flow item (SGD K)

Cash flow item (SGD K)FY2023FY2024FY2025

Net cash used in operating activities

-1,141.7-3,288.9-14,041.0

Capital expenditure (PP&E plus intangibles)

-35.0-22.8-1.6

Free cash flow

-1,176.7-3,311.6-14,042.6

Proceeds from share issuance, net

1,592.43,341.016,836.9

Related-party loan proceeds

0.01,264.30.0

Related-party loan repayments

-312.40.0-2,401.8

Deferred offering costs paid

-105.6-751.70.0

Net cash from financing

1,174.53,853.614,435.1

Dividends paid

000

Share buybacks

000

Year-end cash

15.0546.31,163.9

Financial Ratios (x) and Returns & Leverage Ratios (%)

RatioFY2023FY2024FY2025

Current ratio (x)

—0.340.29

Debt to equity (x)

—-3.28-1.07

Interest coverage, operating loss / interest (x)

-14.3-14.5-186.4

Return on average assets (%)

——-613.6

Asset turnover (x)

——0.03

Geographic Revenue

RegionFY2024FY2025Commentary

Singapore

——

Headquarters and principal customer base

Malaysia

——

Distribution subsidiary (GrowHub Malaysia)

Australia

——

Both Australian subsidiaries deregistered Dec 2025; expect nil going forward

Japan

——

Trading subsidiary in Kansai region

Vietnam

——

Entity acquired Feb 2025, deregistered Oct 2025

Americas / EMEA

Nil

Nil

Srpska MoU (EMEA) is non-revenue to date; EnChem merger would shift the group to the U.S.

Revenue by Region (%)

Customer concentration (% of revenue)FY2022FY2023FY2024FY2025

Largest customer

66.458.640.051.1

Top five customers

91.589.790.4—

Share Price History

DatePrice (USD)ContextSource

27 Aug 2025

4.00

IPO price

Press release

9 Sep 2025

-27.5% on the day

Srpska MoU announcement

StockTitan

Dec 2025

Below 1.00 for 30 business days

Nasdaq bid-price notice

20-F

20 Mar 2026

0.32—

Seeking Alpha

23 Jun 2026

0.45 (market cap US$11.1M)

Post-delisting determination

Benzinga

Early Jul 2026

1.52 (+86.6% on the day; market cap US$15.3M)

Merger-related rally

Benzinga (page dated 4 Jul 2026)

3 Sep 2026

0.8805 (market cap US$22.3M)

—

StockAnalysis

~9 Oct 2026

about 0.74 (market cap about US$18.7M)

—

Meyka

Share price metric

Value

——

Return since IPO (to about 9 Oct 2026)

-81.5% (analyst calculation, US$4.00 to about US$0.74)

——

1-year return

Not computed: no verified price for Oct 2025

——

3-year / 5-year return

Not applicable (listed Aug 2025)

——

52-week range

US$0.27–3.75 (StockAnalysis, Sep 2026) vs US$0.27–4.25 (Benzinga, Jun–Jul 2026); the sources conflict on the high

——

Volatility

Average weekly movement about 23.8% (Simply Wall St)

——

Valuation Multiples

MultipleTGHLComment

Market capitalization (USD Mn)

18.7

25.30M shares

Enterprise value (USD Mn)

20.3

Plus related-party loan US$2.45M, less cash US$0.91M (31 Dec 2025 balances)

EV/Sales (x)

314

On FY2025 revenue US$64.6k

P/Sales (x)

290—

Capital Markets

ItemStatus

Analyst consensus

None. No sell-side coverage identified.

Dividend history and policy

Never paid; the 20-F states no plans for the foreseeable future, and Cayman law restricts distributions

Credit ratings (Moody's, S&P, Fitch)

Not rated

Debt maturity profile

Related-party loan of S$3.15M (US$2.45M), unsecured, 3% p.a., repayable within 60 days of demand; operating leases of S$14.1k. No bank or public debt.

Warrants

375,000 underwriter warrants at US$5.00; expire 27 Aug 2030

Authorized capital (post-Aug 2026)

5,000,000,000 Class A and 50,000,000 Class B (US$2.525M)

Approved reverse split

Up to 1:200, at board discretion within 12 months of 5 Aug 2026

Shares outstanding (million)

FY2023

Class A

11.12

Class B

10.43

Total

21.55

Analyst Conclusions

Management guidance and consensus

No financial guidance has been issued and there is no consensus. The only forward-looking corporate commitments are the merger milestones: an EGM to approve the merger, SEC registration, Nasdaq approval, Class B conversion, and closing by 2 Dec 2026.

Bull case

  1. The merger closes and the listing is preserved. TGHL becomes the U.S.-listed home of EnChem America, valued at US$379.7–428.3M by an independent evaluator. At the agreed terms, legacy holders' 15% implies about US$70.6M against a US$19–22M market cap.

  2. Funded U.S. ESS growth story. EnChem plans a US$200M+ U.S. raise and has an existing Georgia plant. It has been selected as an LFP electrolyte supplier to North American ESS lines and targets more than 8,000 tons of North American ESS shipments in 2026.

  3. Governance reset. Closing eliminates super-voting Class B shares, replaces the board and management with EnChem designees (at least three independent directors), and ends reliance on founder demand loans.

Bear case

  1. Deal or listing failure. The Panel exception and merger outside date coincide on 2 Dec 2026. The term-sheet US$4.00 VWAP floor, the SEC registration timetable and the need to meet initial listing standards are all binding constraints. If the deal fails, TGHL is a company with S$83k revenue, negative equity and a demand loan from its controlling shareholder.

  2. Legacy business has no standalone value. Revenue fell 65%, intangibles were fully written off, Australia and Vietnam were exited, and FY2025 operating cash burn was S$14.0M against year-end cash of S$1.16M.

  3. Dilution and capital-structure overhang. Holders face about 85% merger dilution, authorized capital of 5bn shares, a reverse split of up to 1:200, and a US$200M shelf plus planned capital calls. Post-closing value per legacy share could be diluted further by financing at depressed prices.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
Filing and SEC effectiveness of merger registration statement (F-1/F-4)Q4 2026Gating item for closing; will disclose EnChem America's audited financials for the first time
Board decision on reverse-split ratio and effective dateBy Aug 2027 (12-month window); likely before closingRequired for US$1 bid price and Nasdaq initial listing standards
EGM to approve the mergerQ4 2026Controlling-shareholder voting agreement makes approval highly likely
Nasdaq approval of merger-share listing and Panel compliance determinationBy 2 Dec 2026Binary listing outcome
Merger closing or terminationBy 2 Dec 2026 outside dateDetermines the company's identity
CFO successionOngoingFinancial reporting continuity
H1 2026 interim results (6-K)By end-2026 under FPI timingCash runway and the professional-fee trajectory
Resolution of the S$3.15M CEO demand loanAt or before closingLiquidity and related-party exposure
Post-merger US$200M shelf and first capital call2,027Funding of the Georgia plant; dilution
EnChem ESS volumes (North America)2026–2027Fundamental value driver of the post-merger entity

Analyst verdict

The GrowHub Limited, as it has operated to date, is not an investable operating business. It is a listing in transition. Over FY2023–FY2025 the traceability-and-trading model produced S$448.6k of cumulative revenue against S$21.4M of cumulative net losses. Its only growing revenue line, subscriptions, reached just S$23.6k. Within four months of a US$15M IPO, the company booked S$12.9M of professional fees and wrote off its S$1.99M platform intangible. It exited Australia and Vietnam and ended FY2025 with negative equity of US$2.30M and a US$2.45M demand loan from its founder. Internal-control material weaknesses, an auditor change, a late annual report, a CFO resignation and boilerplate inconsistencies in the 20-F all point to thin governance and financial-reporting infrastructure.

The investment case therefore rests almost entirely on the EnChem America reverse merger. On paper the terms are generous to legacy holders: a 15% stake in a business independently valued at about US$380–428M implies roughly 3.5x the current market capitalization. The discount reflects real, binary risks. Nasdaq requires the combined company to meet initial listing standards by 2 Dec 2026, the same date as the merger's outside date. An SEC registration statement must become effective within weeks. The term sheet included a US$4.00 VWAP floor that the stock has not approached since its debut month. EnChem America's own audited financials have not yet been published, so the quality of the asset being injected cannot be independently assessed.

Verdict: a high-risk special situation, not a fundamental holding. Any position is a bet on deal completion, sized for possible total loss. The decisive monitorables are the merger registration filing, which will contain EnChem America's audited financials; the reverse-split execution; and Nasdaq's compliance determination by 2 December 2026. If the deal fails, the standalone business offers no credible path to solvency without continued founder support.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenureBackgroundSource

Chan Choon Yew Lester

Founder, Chairman, CEO, Director; Controlling Shareholder

Founder of operating group 2020; holdco Chairman/CEO since 2024

Former CEO, Fund Singapore Pte Ltd (2016–2022); former Director, Beaconrock Consultancy Pte Ltd (2009–2016). Undergraduate degree, National University of Singapore; MBA, Singapore Management University.

20-F; Zonebourse/MarketScreener insider profile

Poh Chit Wen

Chief Financial Officer

Listed as CFO on 20-F cover (May 2026); Form 3 filed Apr 2026

Resigned 31 Jul 2026 for personal reasons; effective date to be agreed.

20-F; 6-K 4 Aug 2026

Alec Ngo

Chief Operating Officer (as of the platform launch coverage)

——

Quality Assurance & Food Safety magazine

Chai Chun Kiat

CTO (appointment announced Mar 2023)

——

Asia Food Journal, Mar 2023

Aaron Loo Jian Lin

Chief Innovation Officer (appointment announced Mar 2023)

——

Asia Food Journal, Mar 2023

Board of Directors

NameRoleIndependenceCommitteesBackgroundSource

Chan Choon Yew Lester

Chairman and CEO

Executive; controlling shareholder

—

See above

20-F

Jiao Jie

Director

Independent

Audit (Chair); Compensation; Nominating & Corporate Governance

—

6-K Feb 2026

Yam Yuet Hang

Director

Independent

Compensation (Chair); Audit; Nominating & Corporate Governance

—

6-K Feb 2026

Liu Wing Ki

Director (appointed 14 Feb 2026)

Independent (committee member)

Nominating & Corporate Governance (Chair); Audit; Compensation

VP, Sing Hoi International Holding (since 2023), overseeing finances; finance/accounting at Healthlase Medical Skin Centre (2019–2020); BA (Hons) Accountancy, University of Portsmouth (2010)

6-K Feb 2026

Kim Ji Yeon

Director (appointed 14 Feb 2026)

Independent (committee member)

Audit; Compensation; Nominating & Corporate Governance

CEO, Duble J Company (Nov 2024–Dec 2025); strategy and promotion, CJ ENM (2023–2024); brand and content strategy for tvN and tvN Story (2011–2023); media and communications degree, Yonsei University (2004)

6-K Feb 2026

Tan Kim Han Raymond

Former independent director

Independent

—

Resigned effective 13 Feb 2026 for personal reasons; no disagreement disclosed

6-K Feb 2026

Major Shareholders

HolderSharesEconomic stake (%)Voting power (%)Source

Chan Choon Yew Lester, via Initium Novum Capital, Vita Nova Ventures and EMJ Capital Holdings

10,433,340 Class B

41.2

about 87.53

20-F; Form 3, Apr 2026

Other Class A holders, including pre-IPO investors and IPO and resale shareholders

14,866,470 Class A

58.8

about 12.47

20-F

Alexander Capital, L.P. (underwriter warrant)

Warrant over 375,000 Class A at US$5.00; exercisable from 24 Feb 2026 to 27 Aug 2030

——

20-F equity note

Competitive Landscape

Key Competitors

CompetitorSegmentPositioning vs TGHL

TE-FOOD

Blockchain food traceability (SE Asia, Africa)

Direct APAC peer, also public-chain-based

OriginTrail / Trace Labs

Decentralized knowledge graph for supply-chain data

Larger developer ecosystem

Provenance (UK)

Product transparency and claims verification for consumer brands

Similar consumer-facing proposition with a stronger brand roster

Sourcemap (US)

Supply-chain mapping and traceability for enterprises

Enterprise-grade, regulatory compliance focus (e.g., EUDR)

Wholechain (US)

Food traceability (FSMA 204 compliance)

U.S. regulatory tailwind

Trustwell (formerly FoodLogiQ)

Food safety and traceability SaaS

Established enterprise customer base

Avery Dennison (atma.io connected product cloud)

Item-level digital identity (RFID/NFC)

Global scale; integrated tags plus software

SGS

Testing, inspection, certification, traceability services

Incumbent trust provider

Bureau Veritas

TIC plus traceability and origin verification

Incumbent trust provider

OpSec Security; Authentix

Brand protection and anti-counterfeit

Specialist anti-counterfeit incumbents

Sylvera; Pachama

Carbon-credit ratings and MRV

Specialist carbon MRV

Competitor Detail

MetricTGHL (FY2025)

Revenue

S$83.0k (US$64.6k)

Revenue growth

-65.0%

Operating margin

-20,382%

Recent Developments

No interim H1 2026 financial statements were located as of the research date.

Company Snapshot

$0.1M

Revenue

$18.7M

Market Cap

2024

Founded

Paya Lebar Quarter One, Singapore

Headquarters

SWOT Analysis

Strengths

  • Nasdaq listing: The listing itself has strategic value, demonstrated by EnChem's willingness to transact at a US$400M target valuation for an 85% stake (merger agreement, 14 Jul 2026).
  • Committed controlling shareholder: The CEO has funded the group directly through loan agreements of up to S$8M (Jan 2025) and his father's facility of up to S$6M.
  • Majority-independent board with fully independent committees: Four of five directors are independent following the Feb 2026 changes (6-K, 17 Feb 2026).
  • Low capital intensity: Capex was S$1.6k in FY2025 and the platform runs on third-party infrastructure (20-F).
  • Recurring element growing: Subscription revenue rose from S$4.3k (FY2023) to S$21.7k (FY2024) and S$23.6k (FY2025). Small in absolute terms, but it is the only stream growing for three consecutive years.
  • Shareholder approvals secured: The EGMs of 5 Aug 2026 passed all resolutions by margins above 99.99% of votes cast, removing capital-structure obstacles to the merger.

Weaknesses

  • Negligible revenue: S$83.0k in FY2025, down 65% YoY; derived H2 2025 revenue about S$19.7k.
  • Severe losses: Net loss of S$17.2M in FY2025, about 207 times revenue; accumulated deficit S$23.9M.
  • Negative equity and liquidity gap: Shareholders' deficit of US$2.30M; current liabilities exceed current assets by US$2.36M (20-F).
  • Dependence on related-party demand loans: S$3.15M owed to the CEO, repayable on 60 days' demand at 3%.
  • Material weaknesses in internal control across FY2023–FY2025, citing insufficient U.S. GAAP and SEC expertise and inadequate segregation of duties (20-F).
  • Disclosure quality concerns: The 20-F contains apparent boilerplate from other issuers, including references to "car dealers" and "patient" information in the risk factors. Its XBRL cybersecurity disclosure appears to describe a shipping business. There are also inconsistent HQ addresses and an internally inconsistent FY2023 customer-concentration figure (89.7% vs 93.8%).

Opportunities

  • Re-rating through the merger: Analyst arithmetic implies about US$70.6M for legacy holders' 15% at the deal valuation, against a US$19–22M market cap.
  • U.S. ESS electrolyte demand: EnChem was selected as an LFP electrolyte supplier for North American ESS lines, with about 5,000 tons expected and a target above 8,000 tons of North American ESS shipments in 2026 (Asia Business Daily, 23 Jul 2026).
  • Parent-backed supply base: EnChem's CATL contract covers 350,000 tons over five years through 2030, and it has 220,000 tons of China capacity.
  • Capital-markets access: A shelf of at least US$200M and a planned US$200M+ post-merger raise would fund the Georgia plant (term sheet; Asia Business Daily, 29 Jul 2026).
  • Regulatory traceability mandates: FSMA 204 and the EUDR could create residual demand if the traceability business were spun out or sold. No such plan has been disclosed.
  • Government carbon and ESG projects: The Srpska MoU covers carbon monitoring of reforestation and forest-preservation projects. It is non-binding.

Threats

  • Delisting: The Nasdaq Panel exception expires 2 Dec 2026. The company must meet initial listing standards because of the change of control (6-K, 3 Aug 2026).
  • Merger failure risk: The term-sheet US$4.00 VWAP floor compares with a recent price of about US$0.74 pre-split. Closing also requires an effective SEC registration, Nasdaq approval and timing within the 2 Dec 2026 outside date.
  • Massive dilution: Legacy holders fall to about 15% of the company. The reverse split of up to 1:200 and authorized capital of 5bn Class A shares permit further issuance.
  • CFO departure: The CFO resigned 31 Jul 2026, during merger registration and PCAOB audit work.
  • EV and battery cyclicality and U.S. policy risk for the target business: EnChem is shifting its North American mix from EV to ESS electrolyte (Asia Business Daily).
  • Liquidity squeeze: Cash of S$1.16M at end-2025 against FY2025 operating burn of S$14.0M and a S$3.15M demand loan.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Feb 2025 (context)GrowHub Vietnam acquired from a common directorRelated-party acquisition ahead of IPO
H1 2025Interim: revenue S$63.3k (H1 2024: S$180.5k); net loss S$1.84M; cash S$275k at 30 Jun 2025; shareholders' deficit S$3.73MPre-IPO deterioration and reliance on related-party funding
25 Aug 2025F-1 declared effectiveClears IPO
27 Aug 2025IPO priced: 3.75M Class A at US$4.00 (US$15M gross); Alexander Capital lead, Network 1 co-underwriter; 2M-share non-underwritten resale offeringListing secured, below the original US$4–5 range midpoint
28 Aug 2025First day of trading on NasdaqPublic listing
29 Aug 2025IPO closing announcedUS$15M gross; estimated net about US$12.0M
9 Sep 2025Srpska MoU; stock fell 27.5% that dayFirst post-IPO business announcement; market reaction negative
Oct 2025Vietnam subsidiary deregisteredRetrenchment
3/5 Dec 2025Nasdaq bid-price deficiency notice (below US$1 for 30 business days); compliance deadline 1 Jun 2026Shares fell below US$1 about three months after a US$4 IPO
Dec 2025Australian subsidiaries deregisteredExit from Australia; Innovation Centre ended
FY2025 (H2)S$12.9M professional fees and S$1.99M intangible write-off bookedDrives FY2025 net loss of S$17.2M
13 Feb 2026Independent director Raymond Tan resignsBoard turnover
14 Feb 2026Kim Ji Yeon and Liu Wing Ki join board; committees reconstitutedBoard refresh
24 Feb 2026Underwriter warrants (375k at US$5.00) become exercisableDeep out of the money
3 Mar 2026Auditor change: Assentsure PAC replaces Audit Alliance LLP for FY2025Change shortly before the first annual audit as a listed company
13–14 Apr 2026Form 3 filings by the CEO, CFO and four directorsInsider reporting
Apr 2026NT 20-F filedLate annual report
15 May 2026FY2025 20-F filed: net loss US$13.38M; material weaknesses; shareholders' deficit US$2.30MTriggers equity deficiency
20 Mar to 23 Jun 2026Shares trade around US$0.32–0.45 (Seeking Alpha; Benzinga)Market cap around US$8–11M
26–29 May 2026Nasdaq equity deficiency notice (Rule 5550(b)(1)); plan due 10 Jul 2026Second listing deficiency
28–29 May 2026Binding term sheet with EnChem America (85/15 split; US$400M minimum value; US$4.00 floor)Pivot announced; stock rallied
1 Jun 2026Bid-price compliance period expiresEscalation
5 Jun 2026Nasdaq Staff Delisting Determination; company requests hearing (press release 10 Jun)Delisting risk crystallized
14 Jul 2026Definitive merger agreement and voting agreement signedDeal committed; board unanimous
15 Jul 2026Korean press (Edaily) reports EnChem's U.S. listing route via TGHLConfirms counterparty commitment
16 Jul 2026Nasdaq Hearings Panel hearingCompliance plan presented
17 Jul 2026EGM notice issued (record date 30 Jun 2026)Capital restructuring launched
23 Jul 2026EnChem outlines ESS-focused growth in China and North America; Georgia plant qualifying LFP electrolyteContext on target's prospects
29 Jul 2026Nasdaq Panel grants exception to 2 Dec 2026, conditional on demonstrating initial listing standards. Korean press: Samdo Accounting fair-value range US$379.7–428.3M; EnChem plans US$200M+ U.S. raise post-merger.Listing preserved temporarily; valuation support for target
31 Jul 2026CFO Poh Chit Wen resigns (effective date to be agreed)Finance leadership gap before a complex merger
5 Aug 2026EGMs approve new articles, authorized capital raised to 5.05bn shares, and reverse split up to 1:200Mechanical prerequisites for merger and compliance
3 Sep 2026Close US$0.8805; market cap US$22.3MPost-announcement level
~9 Oct 2026Quote about US$0.74 (Meyka)Market cap about US$18.7M

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue fell from SGD 0.1 Mn in FY2023 to SGD 0.1 Mn in FY2025.
The GrowHub Limited — Income Statement: Revenue & Gross Profit
Series (SGD Mn)FY2023FY2024FY2025
Revenue0.10.20.1
Gross profit (revenue less direct costs)00.1-0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. FY2025 Form 20-F, The GrowHub Limited (filed 15 May 2026) (sec.gov)
  2. FY2025 20-F XBRL statements and notes: balance sheet (R2), operations (R4), equity (R5), cash flows (R6), cybersecurity (R9), organization (R10), equity note (R18), related parties (R19), revenue (R20), subsequent events (R25), policies narrative (R46), intangibles (R54), other expenses (R67) (sec.gov)
  3. Form 424B4 prospectus (Aug 2025) (sec.gov)
  4. Form F-1 (Oct 2024) (sec.gov)
  5. 6-K, H1 2025 interim financial statements (sec.gov)
  6. 6-K, Srpska MoU (9 Sep 2025) (sec.gov)
  7. 6-K, EnChem term sheet (Jun 2026) (sec.gov)
  8. 6-K, Merger agreement (15 Jul 2026) (sec.gov)
  9. 6-K, EGM notice (17 Jul 2026) (sec.gov)
  10. 6-K, Nasdaq Panel decision (3 Aug 2026) (sec.gov)
  11. 6-K, EGM results (6 Aug 2026) (sec.gov)
  12. StockTitan, 6-K board changes (Feb 2026) (stocktitan.net)
  13. StockTitan, 6-K CFO resignation (Aug 2026) (stocktitan.net)
  14. StockTitan, TGHL filings index (pages 1–2) (stocktitan.net)
  15. StockTitan, FY2025 20-F summary (stocktitan.net)
  16. StockTitan, Srpska MoU press release (stocktitan.net)
  17. PR Newswire / PRNAsia, IPO closing (29 Aug 2025) (en.prnasia.com)
  18. Barchart, IPO pricing release (barchart.com)
  19. Renaissance Capital, IPO filing coverage (Oct 2024) (renaissancecapital.com)
  20. Renaissance Capital, company profile (renaissancecapital.com)
  21. Asia Food Journal, pre-Series B first close (10 Mar 2023) (asiafoodjournal.com)
  22. Quality Assurance & Food Safety, platform launch coverage (qualityassurancemag.com)
  23. Asia Business Daily, EnChem valuation and US$200M funding plan (29 Jul 2026) (view.asiae.co.kr)
  24. Asia Business Daily, EnChem ESS shipments (23 Jul 2026) (view.asiae.co.kr)
  25. Edaily (15 Jul 2026) (en.edaily.co.kr)
  26. Panabee, EnChem merger summary (AI-generated; used for cross-check only) (panabee.com)
  27. Panabee, share capital increase and reverse split (AI-generated; cross-check only) (panabee.com)
  28. Zonebourse / MarketScreener, Choon Yew Chan insider profile (ch.zonebourse.com)
  29. StockAnalysis, TGHL quote (3 Sep 2026) (stockanalysis.com)
  30. Meyka, TGHL quote (about 9 Oct 2026) (meyka.com)
  31. Benzinga, TGHL report pages (Jun–Jul 2026): and: fr.benzinga.com · jp.benzinga.com
  32. Seeking Alpha, TGHL growth page (20 Mar 2026 price) (seekingalpha.com)
  33. Simply Wall St, TGHL (simplywall.st)
  34. AlphaQuery, TGHL fundamentals (alphaquery.com)
  35. Quantisnow, TGHL filings feed (quantisnow.com)
  36. tldrfiling, TGHL filings list (tldrfiling.com)
  37. AmericanCompanies.com, GrowHub Ltd profile (employee count) (americancompanies.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.